Pancreatic cancer has a very low 5 year survival rate at only around 5%. This is due to the presenting symptoms, which are not normally diagnosed as pancreatic cancer until the diseases later stages. At this point chemotherapies and surgery are largely ineffective.
Researchers at Emory Univeristy in the United States have created nanotools that specifically bind pancreatic cancers. This makes the cancers clearly show up on MRI scans allowing hopefully earlier detection.
This could be a great step forward in the diagnosis of one of the most lethal cancers, which presumably would reduce 5 year mortality rates – CT